Status
Conditions
About
This is an observational phase IV study evaluating Niraparib as maintenance treatment in patients with platinum sensitive, platinum responsive, recurrent ovarian cancer in a real life setting.
Full description
This is an observational phase IV study evaluating Niraparib as maintenance treatment in patients with platinum sensitive, platinum responsive, recurrent ovarian cancer in a real life setting. Will be enrolled all patients who have been part of the Italian Compassionate Use Program (CUP) prior to participating in this study. Once the CUP will be closed the trial will continue with th prospective collection of data of patients treated with Niraparib according to the label for 2 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
No exclusion criteria
Loading...
Central trial contact
Domenica Lorusso, MD; Serena Giolitto, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal